INTS vs NIO · $7.7M cap vs rev $12.51B
Intensity Therapeutics, Inc. Common stock (INTS) versus Nio Inc Class A ADR (NIO) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Nio Inc Class A ADR (NIO) is a auto manufacturers company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported NIO revenue for 2025-12-31 was $12.51B. Net income was -$2.14B. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. NIO currently screens at market cap $7.61B.
INTS currently screens at market cap $7.7M. NIO currently screens at market cap $7.61B.
Not investment advice. Open the INTS and NIO stock pages for the full models.
Not investment advice.